calendar
3,922 catalysts · 3,728 phase readout · 2,103 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
3,922 catalysts · 3,728 phase readout · 2,103 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL
Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: BRISTOL. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL
Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR
Supplement type: 30-Day Notice. Product code: MDP. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QZK. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MFE. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: MCM. Advisory committee: EN. Decision: OK30
Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: 30-Day Notice. Product code: MOZ. Advisory committee: OR. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: OAD. Advisory committee: CV. Decision: OK30
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: TIANJIN TIANYAO. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL